Pear Therapeutics, Inc. filed an asset purchase agreement in the US Bankruptcy Court for the sale of certain assets on May 21, 2023. As per the agreement dated May 21, 2023, seeks the Court?s approval for the sale of certain assets to Harvest Bio LLC for a purchase price of $2.03 million in cash plus assumption of the assumed liabilities plus any cure costs. The debtor?s assets include Invention Science Fund licenses and patents, schizophrenia (Pear-004), multiple sclerosis and depression (Pear-006), major depressive disorder, other pipeline assets, corporate trademarks, PearConnect, and reSET® and reSET-O®.

The buyer is represented by Michael Kuh of Hogan Lovells US LLP as its legal advisor.